New Alzheimer's drugs 5 to 10 years away, expert says

03/19/2009 | Google

Experimental drugs that stopped or stalled the progression of Alzheimer's disease in late-stage studies could be launched in five to 10 years, said Simon Lovestone of the Institute of Psychiatry at King's College London. As many as 11 Alzheimer's treatments are in Phase III trials, and about 80 more are in early-stage development.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations